CD276 and lung carcinoma: concluded that the pharmacological inhibition of CD276 exerts remarkable effects when CD276 is located on the cell membrane, and the bispecific antibody anti-CD3 × anti-CD276 has been shown to exert significant antitumor activity and to inhibit lung cancer metastasis.